Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.10 USD
-0.11 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.11 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
FMS 20.10 -0.11(-0.54%)
Will FMS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FMS
Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
Paragon 28, Inc. (FNA) Moves 16.2% Higher: Will This Strength Last?
Other News for FMS
GLOBAL BROKER RATINGS: Stifel cuts Caterpillar; HSBC likes Ashtead
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
Doctors perform first combined heart pump and pig kidney transplant surgery
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
FMS Crosses Above Key Moving Average Level